2-fluoro Palmitic Acid
(Synonyms: 2-氟十六酸) 目录号 : GC17218Inhibitor of sphingosine biosynthesis and long-chain acyl-CoA synthetase
Cas No.:16518-94-8
Sample solution is provided at 25 µL, 10mM.
2-fluoropalmitic acid inhibits sphingosine biosynthesis and long-chain acyl-CoA synthetase [1]. The length of the carbon chain of the fatty acid species defines the substrate specificity for the different acyl-CoA synthetases (ACS).
Mammalian long-chain acyl-CoA synthetases (ACSL) activate fatty acids with chain lengths of 12 to 20 carbon atoms. The long-chain acyl-CoA synthetase mRNA is expressed virtually in heart, liver, and epididymal adipose tissues and, to a much lesser extent, in brain, small intestine, and lung [2].
Palmitic acid was a selective cytotoxic substance extracted from the marine algal. At concentrations ranging from 12.5 to 50 μg/ml, palmitic acid showed selective cytotoxicity to human leukemic cells, but no cytotoxicity to normal HDF cells. Palmitic acid (50 μg/ml) induced apoptosis in the human leukemic cell line MOLT-4. Palmitic acid also showed in vivo antitumor activity in mice [3]. 2-fluoropalmitic acid showed an inhibitory effect on sphingosine biosynthesis and long-chain acyl-CoA synthetase with an IC50 value of 0.2 mM [1].
References:
[1] Soltysiak R M, Matsuura F, Bloomer D, et al. d, l-α-fluoropalmitic acid inhibits sphingosine base formation and accumulates in membrane lipids of cultured mammalian cells[J]. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism, 1984, 792(2): 214-226.
[2] Suzuki H, Kawarabayasi Y, Kondo J, et al. Structure and regulation of rat long-chain acyl-CoA synthetase[J]. Journal of Biological Chemistry, 1990, 265(15): 8681-8685.
[3] Harada H, Yamashita U, Kurihara H, et al. Antitumor activity of palmitic acid found as a selective cytotoxic substance in a marine red alga[J]. Anticancer research, 2001, 22(5): 2587-2590.
Cas No. | 16518-94-8 | SDF | |
别名 | 2-氟十六酸 | ||
化学名 | 2-fluorohexadecanoic acid | ||
Canonical SMILES | CCCCCCCCCCCCCCC(F)C(=O)O | ||
分子式 | C16H31FO2 | 分子量 | 274.4 |
溶解度 | Soluble in DMSO | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 3.6443 mL | 18.2216 mL | 36.4431 mL |
5 mM | 0.7289 mL | 3.6443 mL | 7.2886 mL |
10 mM | 0.3644 mL | 1.8222 mL | 3.6443 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet